Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis
September 07, 2025 18:25 ET | Source: Dianthus Therapeutics, Inc. NEW YORK…
Cango Inc. Reports Second Quarter 2025 Unaudited Financial Results
HONG KONG, Sept. 4, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today announced…
Zoomlion Reports Strong First-Half 2025 Results, Driven by Global Growth and Tech Innovation
CHANGSHA, China, Sept. 4, 2025 /PRNewswire/ -- Zoomlion Heavy Industry Science &…
SERES Posts Robust H1 2025 Results: Revenue Hits CNY 62.4 Billion, Net Profit Up 81% to CNY 2.94 Billion, R&D Investment Soars nearly 155%
CHONGQING, China, Sept. 3, 2025 /PRNewswire/ -- On August 29, SERES announced its…
Kia Announces August 2025 Global Sales Results
August 2025 global sales of 253,950 units, up 0.8% Y/ySales in Korea…
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
ZUG, Switzerland, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Phase 2 ACUITY trial…
Anavar For Women And Men: CrazyBulk Launch Anavar Legal Steroid Alternative For Female Read Dosage, Side Effects, (Before and After Cycle results)
New York, Aug. 31, 2025 (GLOBE NEWSWIRE) -- August 31, 2025 |…
Voxtur Announces Financial Results Delay for Q2 2025
August 29, 2025 19:10 ET | Source: Voxtur Analytics Corp. TORONTO and…
IBEX Limited to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on September 11, 2025
August 28, 2025 16:30 ET | Source: Ibex Limited WASHINGTON, Aug. 28,…
Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated August 28,…
